Litcius/Paper detail

The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice

Pedro H. Reis‐Barbosa, Ilitch Aquino Marcondes‐de‐Castro, Thatiany de Souza Marinho, Márcia Barbosa Águila, Carlos Alberto Mandarim‐de‐Lacerda

2022Clinics and Research in Hepatology and Gastroenterology45 citationsDOI

Topics & Concepts

SemaglutideAMPKInternal medicineLipogenesisEndocrinologyMedicinemTORC1PI3K/AKT/mTOR pathwayLipid metabolismAgonistGlucagon-like peptide 1 receptorType 2 diabetesReceptorSignal transductionLiraglutideProtein kinase ABiologyDiabetes mellitusKinaseBiochemistryMetabolism, Diabetes, and CancerDiabetes Treatment and ManagementAdipose Tissue and Metabolism
The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice | Litcius